Monash IVF Group Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Monash IVF Group ha un patrimonio netto totale di A$246.7M e un debito totale di A$59.6M, che porta il suo rapporto debito/patrimonio netto a 24.1%. Le sue attività totali e le sue passività totali sono rispettivamente A$508.5M e A$261.8M.

Informazioni chiave

24.1%

Rapporto debito/patrimonio netto

AU$59.57m

Debito

Indice di copertura degli interessi	n/a
Contanti	AU$11.33m
Patrimonio netto	AU$246.66m
Totale passività	AU$261.81m
Totale attività	AU$508.47m

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( { MVF di A$55.8M ) non coprono le sue passività a breve termine ( A$118.8M ).

Passività a lungo termine: Le attività a breve termine di MVF ( A$55.8M ) non coprono le sue passività a lungo termine ( A$143.0M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 19.6% ) di MVF è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di MVF si è ridotto da 51.6% a 24.1% negli ultimi 5 anni.

Copertura del debito: Il debito di MVF è ben coperto dal flusso di cassa operativo ( 88.2% ).

Copertura degli interessi: Dati insufficienti per determinare se i pagamenti degli interessi sul debito di MVF siano ben coperti dall'EBIT.

Monash IVF Group Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought AU$192k worth of stock

New 90-day low: AU$0.70

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

New 90-day high: AU$0.72

New 90-day high: AU$0.65

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane